The Integrated Bioinformatic Assay of Genetic Expression Features and Analyses of Traditional Chinese Medicine Specific Constitution Reveal Metabolic Characteristics and Targets in Steatosis of Nonalcoholic Fatty Liver Disease
Chunping Qiao,Chengying Gu,Song Wen,Yanju He,Sheng Yang,Xinge Feng,Yipeng Zeng
DOI: https://doi.org/10.2147/hmer.s428161
2023-10-06
Hepatic Medicine Evidence and Research
Abstract:Chunping Qiao, 1, &ast Chengying Gu, 2, &ast Song Wen, 3, &ast Yanju He, 3 Sheng Yang, 4 Xinge Feng, 5 Yipeng Zeng 5 1 Department of Gastroenterology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China; 2 Department of Examination, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China; 3 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China; 4 Laogang Community Health Center, Shanghai, People's Republic of China; 5 Department of Internal Medicine of Traditional Chinese Medicine, Pudong Hospital, Fudan University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yipeng Zeng, Department of Internal medicine of Traditional Chinese Medicine Pudong Hospital, Fudan University, Shanghai, 201399, People's Republic of China, Tel +86 18918928802, Email Purpose: In this study, our primary aim is to analyze the genetic expression feature and analyze specific Traditional Chinese medicine (TCM) constitution distribution in non-alcoholic fatty liver disease (NAFLD) and reveal the metabolic characteristic of NAFLD. Materials and Methods: For revealing genetic features, we obtained the gene expression data from the Gene Expression Omnibus (GEO) database of the National Center for Biotechnology Information (NCBI). The genetic data on NAFLD were analyzed by identifying differentially expressed genes (DEGs), associated pathways, co-expressed genetic networks, and gene set enrichment function. Concurrently, we assessed specific constitution distributions among local NAFLD patients through established TCM constitution models and determined the independent variable, including specific constitution to the NAFLD via the regression analyses. Results: The analyses on GEO datasets showed that simple steatosis in NAFLD is strongly associated with HOMA-insulin resistance (HOMA-IR). Analyses of GEO datasets revealed significantly altered genetic expression profiles between NAFLD and normal populations. For TCM constitution analyses, we demonstrated a decline in yin-yang harmony (YYH) and yang-asthenia (YAAC) constitution, whereas there was an increase in qi-stagnation (QSC) and phlegm-dampness (PDC) in NAFLD. The binary logistic regression analysis indicated that besides other metabolic parameters, YYH, qi asthenia (QAC), YYAC, and yin-asthenia (YAC) were the independent variables of NAFLD, while YAC was the independent variables of T2D. The multilinear regression analyses suggested that NAFLD, DM, BMI, waist, TC, TG, hypertension, ALT, AST, and YAC were the significant determinators of the FPG. Conclusion: This study presents a relatively comprehensive metabolic profile in steatosis of NAFLD, revealed by significant genetic expression feature alterations and different TCM constitution distribution in NAFLD. Through this method, the study intends to associate the genetic feature with the phenotype of TCM constitution. The results could be applied to assist integrative medicine research in exploring the appropriate personalized approaches for NAFLD. Keywords: NAFLD, T2D, bioinformatics, TCM constitution The incidence of T2D in China has soared sharply in recent years, with the country recording the highest number of cases worldwide. 1 In obesity-related metabolic diseases, non-alcoholic fatty liver disease (NAFLD) has recently been considered an independent risk factor that induces the early onset of T2D. 2 According to a review study on compiled data of the NAFLD epidemiology, the overall prevalence of NAFLD worldwide was estimated to be 32.4% (95% CI 29.9–34.9). Its prevalence has increased substantially over time, from 25.5% (20.1–31.0) in or before 2005 to 37.8% (32.4–43.3) in 2016 or later (p = 0.013). The overall prevalence of NAFLD was significantly higher in males than in females (39.7% [36.6–42.8] vs 25.6% [22.3–28.8]; p < 0·0001). The overall incidence of NAFLD was estimated to be 46.9 cases per 1000 person-years (36.4–57.5), 70.8 cases per 1000 person-years (48.7–92.8) in males and 29.6 cases per 1000 person-years (20.2–38.9) in female. 3 The prevalence increased in China from 23.8% to 29% from 1999 to 2018, according to a recent study, 4 where NAFLD-related advanced liver disease and its mortality, along with its overall disease burden, are expected to increase substantially. The percentage of total deaths from all causes attributable to NAFLD increased from 0.10% (0.8–0.14%) to 0.17% (0.13–0.23%). 5 Because of the dramatic increase in the global incid -Abstract Truncated-